Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...